 |
|
Methylphenidate in 6-Hydroxydopamine-Treated Developing Rat PupsEffects on Activity and Maze Performance
Bennett A. Shaywitz, MD;
Jeffrey H. Klopper;
Judith W. Gordon
Arch Neurol. 1978;35(7):463-469.
Abstract
• In order to better define the relationship between brain catecholaminergic mechanisms and the clinical syndrome of minimal brain dysfunction, we have developed an experimental model that has many of the features of the disorder seen in children. This model is effected by the preferential depletion of brain dopamine in 5-day-old rat pups following the intracisternal administration of 6-hydroxydopamine, and in the present investigation, we have examined the effects of methylphenidate hydrochloride (0.25 to 2.0 mg/ kg) on activity levels and cognitive performance in normal and 6-hydroxydopamine treated animals. Methylphenidate therapy resulted in a significant increase in activity levels of normal rat pups 12 and 19 days of age; in contrast, methylphenidate administered to 6-hydroxydopaminetreated animals did not increase activity at 12 days of age and significantly reduced activity at 19 and 26 days. Methylphenidate had no effect on T-maze performance in normals, but significantly improved performance in 6-hydroxydopamine-treated animals. Our results suggest that the "paradoxical" response to methylphenidate found in 6-hydroxydopaminetreated rat pups may be the result of central denervation supersensitivity.
Author Affiliations
From the Departments of Pediatrics and Neurology, Yale University School of Medicine, New Haven, Conn.
Footnotes
Accepted for publication April 22, 1977.
Reprint requests to Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510 (Dr Shaywitz).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cortical Thinning of the Attention and Executive Function Networks in Adults with Attention-Deficit/Hyperactivity Disorder
Makris et al.
Cereb Cortex 2007;17:1364-1375.
ABSTRACT
| FULL TEXT
Effects of Norepinephrine and Serotonin Transporter Inhibitors on Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesioning in Rats
Davids et al.
J. Pharmacol. Exp. Ther. 2002;301:1097-1102.
ABSTRACT
| FULL TEXT
Toward a Pathophysiology of Attention-Deficit/Hyperactivint Disorder
Castellanos
CLIN PEDIATR 1997;36:381-393.
ABSTRACT
The Contribution of {alpha}2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder
Arnsten et al.
Arch Gen Psychiatry 1996;53:448-455.
ABSTRACT
Environmental influences on body weight and behavior in developing rats after neonatal 6-hydroxydopamine
Pearson et al.
Science 1980;209:715-717.
ABSTRACT
|
